Stock Analysis on Net
Stock Analysis on Net

Allergan PLC (NYSE:AGN)

This company has been moved to the archive! The financial data has not been updated since May 7, 2020.

Analysis of Inventory

Microsoft Excel

Inventory Disclosure

Allergan PLC, balance sheet: inventory

US$ in thousands

Microsoft Excel
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Raw materials 455,200 303,200 326,900 297,100 242,300
Work-in-process 246,200 145,700 158,100 145,400 149,700
Finished goods 581,700 520,200 527,800 357,700 706,300
Inventories, gross 1,283,100 969,100 1,012,800 800,200 1,098,300
Inventory reserves (150,000) (122,200) (108,300) (82,200) (88,600)
Inventories 1,133,100 846,900 904,500 718,000 1,009,700

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).

Item Description The company
Inventories Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Allergan PLC inventories decreased from 2017 to 2018 but then increased from 2018 to 2019 exceeding 2017 level.